Ā | HCL-32 total | Active/elated | Irritable/risk-taking |
---|---|---|---|
BD1 vs Control | |||
āAUC (95Ā % CI) | 0.56 (0.51ā0.61) | 0.52 (0.47ā0.57) | 0.67 (0.62ā0.72) |
āoptimal cut-off score | >19 | ā„12 | >2 |
āPPV (%) | 38.87 (28.89ā49.60) | 29.72 (23.42ā36.65) | 37.96 (31.07ā45.24) |
āNPV (%) | 77.72 (72.22ā81.52) | 76.53 (70.50ā81.86) | 83.20 (77.77ā87.76) |
āsensitivity (95Ā % CI) | 0.32 (0.24ā0.42) | 0.52 (0.42ā0.62) | 0.65 (0.55ā0.74) |
āspecificity (95Ā % CI) | 0.82 (0.77ā0.86) | 0.56 (0.50ā0.62) | 0.62 (0.56ā0.67) |
BD2 vs Control | |||
āAUC | 0.64 (0.60ā0.69) | 0.54 (0.49ā0.59) | 0.75 (0.70ā0.79) |
āoptimal cut-off score | >21 | >11 | >2 |
āPPV (%) | 53.84 (43.54ā71.23) | 27.20 (22.06ā32.84) | 37.63 (30.82ā44.81) |
āNPV (%) | 81.31 (76.95ā85.17) | 83.27 (76.12ā88.99) | 88.50 (83.60ā92.36) |
āsensitivity (95Ā % CI) | 0.31 (0.22ā0.40) | 0.76 (0.66ā0.83) | 0.74 (0.64ā0.82) |
āspecificity (95Ā % CI) | 0.93 (0.90ā0.96) | 0.37 (0.32ā0.43) | 0.62 (0.56ā0.67) |
BDs vs Control | |||
āAUC | 0.60 (0.56ā0.65) | 0.51 (0.47ā0.56) | 0.71 (0.67ā0.75) |
āoptimal cut-off score | >19 | >10 | >2 |
āPPV (%) | 58.44 (49.66ā66.83) | 43.31 (38.28ā48.46) | 56.07 (49.94ā62.07) |
āNPV (%) | 64.57 (59.65ā69.28) | 63.82 (55.64ā71.45) | 73.99 (68.24ā79.19) |
āsensitivity (95Ā % CI) | 0.36 (0.30ā0.43) | 0.75 (0.68ā0.80) | 0.69 (0.62ā0.75) |
āspecificity (95Ā % CI) | 0.82 (0.77ā0.86) | 0.31 (0.26ā0.37) | 0.62 (0.56ā0.67) |